Read the latest RCOphth news updates and guidance here.
We spoke with Mr. John Ferris about his paper, 'The impact of EyeSi virtual reality training on complications rates of cataract surgery performed by first and second year trainees'. We then spoke with Miss. Preeti Sanghera, an Optometrist working at Moorfields Eye Hospital. She summarised which patients are eligible for free sight tests.
The next government must put the workforce at the heart of its vision for healthcare if it is to create a sustainable eyecare service that meets the needs of patients and staff, says The Royal College of Ophthalmologists (RCOphth) in its general election manifesto, published today.
The Academy of Royal Medical Colleges has produced a short list of available resources and information.
Commenting on the new wellbeing report released by the General Medical Council (GMC).
The Royal College pressed for much needed funding for ophthalmic services during a visit to the college by Health Minister Nadine Dorries to mark World Patient Safety Day.
The Royal College of Ophthalmologists is delighted to open the second Ulverscroft David Owen Award. In memory of David Owen who chaired the Ulverscroft Foundation, the College and the Foundation are offering a £500 prize in recognition of high-quality research in paediatric ophthalmology.
The RCOphth is aware of concern from members and industry regarding the current payment arrangements for Microinvasive Glaucoma Surgery (MIGS). Extensive work has been going on behind scenes, working with the ophthalmology Expert Working Group (EWG), glaucoma specialists and the RCOphth professional standards team.
NHSE/I have published ‘Key areas of work for the 2020 national tariff’ which sets out the key policy areas NHSE/I are considering for 2020 and builds on the engagement webinars and workshops earlier in the year.
The College is offering members the opportunity to propose a seminar topic as part of our annual seminar and events programme.
Allergan has contacted the RCOphth to provide a follow up regarding the hold on XEN 45. Allergan has reached out to regulatory agencies, and is working to initiate a voluntary recall of affected lots of XEN 45.
